Guanoxan

Guanoxan

Clinical data
ATC code	C02CC03 (WHO)
Identifiers
IUPAC name 2-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)guanidine
JSmol)	Interactive image
SMILES c1ccc2c(c1)OCC(O2)CNC(=N)N
InChI InChI=1S/C10H13N3O2/c11-10(12)13-5-7-6-14-8-3-1-2-4-9(8)15-7/h1-4,7H,5-6H2,(H4,11,12,13) N Key:HIUVKVDQFXDZHU-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Guanoxan is a sympatholytic drug that was marketed as Envacar by Pfizer in the UK to treat high blood pressure. It was not widely used and was eventually withdrawn from the market due to liver toxicity.^[1][2]

References